Healthcare provider profile · identity verified

Jorge Antonio Urgell

Nurse Practitioner · HIALEAH, FL · NPI 1659763472

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Diclofenac Sodium	Diclofenac Sodium	528	98
Atorvastatin Calcium	Atorvastatin Calcium	416	128
Gabapentin	Gabapentin	362	100
Pantoprazole Sodium	Pantoprazole Sodium	321	92
Metformin Hcl	Metformin Hcl	314	88
Fluticasone Propionate	Fluticasone Propionate	302	70
Rosuvastatin Calcium	Rosuvastatin Calcium	286	101
Levothyroxine Sodium	Levothyroxine Sodium	264	70
Albuterol Sulfate Hfa	Albuterol Sulfate	262	44
Omeprazole	Omeprazole	237	76
Losartan Potassium	Losartan Potassium	221	71
Meclizine Hcl	Meclizine Hcl	186	44
Metoprolol Succinate	Metoprolol Succinate	179	62
Lisinopril	Lisinopril	178	48
Clopidogrel	Clopidogrel Bisulfate	168	53
Montelukast Sodium	Montelukast Sodium	159	49
Baclofen	Baclofen	153	56
Amlodipine Besylate	Amlodipine Besylate	147	46
Hydrochlorothiazide	Hydrochlorothiazide	130	45
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	129	45
Memantine Hcl	Memantine Hcl	121	36
Tamsulosin Hcl	Tamsulosin Hcl	121	36
Mupirocin	Mupirocin	120	43
Clonidine Hcl	Clonidine Hcl	116	27
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	115	18
Eliquis	Apixaban	114	27
Glipizide	Glipizide	114	27
Ammonium Lactate	Ammonium Lactate	113	32
Valsartan	Valsartan	113	40
Famotidine	Famotidine	112	33
Ketoconazole	Ketoconazole	112	26
Meloxicam	Meloxicam	108	40
Ibuprofen	Ibuprofen	106	31
Vitamin D2	Ergocalciferol (Vitamin D2)	101	36
Simvastatin	Simvastatin	97	27
Metoprolol Tartrate	Metoprolol Tartrate	92	25
Methocarbamol	Methocarbamol	85	39
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	80	16
Trazodone Hcl	Trazodone Hcl	80	16
Triamcinolone Acetonide	Triamcinolone Acetonide	79	21
Mirtazapine	Mirtazapine	77	suppressed
Ondansetron Hcl	Ondansetron Hcl	77	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	77	24
Azithromycin	Azithromycin	75	62
Cyproheptadine Hcl	Cyproheptadine Hcl	69	11
Alendronate Sodium	Alendronate Sodium	67	19
Lantus	Insulin Glargine,hum.Rec.Anlog	67	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	65	18
Ciclopirox	Ciclopirox	61	20
Furosemide	Furosemide	61	23
Citalopram Hbr	Citalopram Hydrobromide	58	15
Hydrocortisone	Hydrocortisone	57	14
Clobetasol Propionate	Clobetasol Propionate	56	16
Pentoxifylline	Pentoxifylline	54	15
Escitalopram Oxalate	Escitalopram Oxalate	53	16
Oxybutynin Chloride Er	Oxybutynin Chloride	53	14
Azelastine Hcl	Azelastine Hcl	51	suppressed
Glipizide Er	Glipizide	49	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	14
Nifedipine Er	Nifedipine	49	19
Sildenafil Citrate	Sildenafil Citrate	48	11
Carvedilol	Carvedilol	47	15
Allopurinol	Allopurinol	45	15
Sertraline Hcl	Sertraline Hcl	44	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	42	11
Alprazolam	Alprazolam	41	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	37
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Potassium Chloride	Potassium Chloride	41	14
Folic Acid	Folic Acid	39	14
Alcohol Pads	Alcohol Antiseptic Pads	38	12
Lactulose	Lactulose	38	12
Naproxen	Naproxen	38	20
Clonazepam	Clonazepam	37	suppressed
Enalapril Maleate	Enalapril Maleate	37	13
Farxiga	Dapagliflozin Propanediol	36	suppressed
Finasteride	Finasteride	35	suppressed
Celecoxib	Celecoxib	33	suppressed
Ciclopirox	Ciclopirox Olamine	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	12
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Entresto	Sacubitril/Valsartan	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Methylprednisolone	Methylprednisolone	31	30
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Labetalol Hcl	Labetalol Hcl	27	suppressed
Santyl	Collagenase Clostridium Hist.	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	13
Linzess	Linaclotide	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	22	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Latanoprost	Latanoprost	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Tadalafil	Tadalafil	21	suppressed
Amoxicillin	Amoxicillin	19	15
Glimepiride	Glimepiride	18	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Ssd	Silver Sulfadiazine	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	17	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	17	16
Buspirone Hcl	Buspirone Hcl	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Cephalexin	Cephalexin	16	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	15
Synthroid	Levothyroxine Sodium	16	suppressed
Temazepam	Temazepam	16	suppressed
Pregabalin	Pregabalin	15	suppressed
Enulose	Lactulose	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Cefdinir	Cefdinir	13	13
Diclofenac Potassium	Diclofenac Potassium	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Lidocaine	Lidocaine	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Prednisone	Prednisone	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Acetic Acid	Acetic Acid	11	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Nadolol	Nadolol	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Tivicay	Dolutegravir Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error